Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer
Authors:
- Ken DarzyKDKen Darzy
- Stephen M. ShaletSSStephen M. Shalet
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 16 (2) , 335-348
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Continuation of Growth Hormone (GH) Replacement in GH-Deficient Patients during Transition from Childhood to Adulthood: A Two-Year Placebo-Controlled StudyThe Journal of Clinical Endocrinology & Metabolism, 2000
- Grading of late effects in young adult survivors of childhood cancer followed in an ambulatory adult settingCancer, 2000
- Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhoodClinical Endocrinology, 1998
- The health status of adult survivors of cancer in childhoodEuropean Journal of Cancer, 1998
- Bone mass acquisition during infancy, childhood and adolescenceActa Paediatrica, 1995
- Population based survival rates for childhood cancer in Britain, 1980-91BMJ, 1994
- Consequences of childhood-onset growth hormone deficiency for adult bone massJournal of Bone and Mineral Research, 1994
- Long-term survival. Clinical care, research, and educationCancer, 1993
- RADIATION‐INDUCED HYPOPITUITARISM IS DOSE‐DEPENDENTClinical Endocrinology, 1989
- THE EFFECT OF VARYING DOSES OF CEREBRAL IRRADIATION ON GROWTH HORMONE PRODUCTION IN CHILDHOODClinical Endocrinology, 1976